Suzanne King is investigating  risk factors for schizophrenia, such as prenatal stress, obstetric complications, and cannabis use.

The research of Myra Piat focuses on housing for persons with serious mental illness and recovery from serious mental illness.

Natalie Grizenko is medical director with the mandate of integrating research, teaching and clinical excellence throughout the program.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Salah El Mestikawy studies neurons using glutamate as a neurotransmitter in healthy and diseased central nervous systems.  

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.  

Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.